The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer’s Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer’s Disease
Authors
Keywords
-
Journal
MOLECULAR NEUROBIOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-29
DOI
10.1007/s12035-021-02385-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Base editing strategy for insertion of the A673T mutation in APP gene to prevent the development of Alzheimer's disease in vitro
- (2021) Antoine Guyon et al. Molecular Therapy-Nucleic Acids
- Opposite changes in APP processing and human Aβ levels in rats carrying either a protective or a pathogenic APP mutation
- (2020) Marc D Tambini et al. eLife
- Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report
- (2020) Ravindra Kumar Gupta et al. Lancet HIV
- The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeutics
- (2020) Sarah A. Kent et al. ACTA NEUROPATHOLOGICA
- Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
- (2020) Tiantian Guo et al. Molecular Neurodegeneration
- HGF Mediates Clinical‐Grade Human Umbilical Cord‐Derived Mesenchymal Stem Cells Improved Functional Recovery in a Senescence‐Accelerated Mouse Model of Alzheimer's Disease
- (2020) Yali Jia et al. Advanced Science
- Human Stem Cell-Derived Neurons Repair Circuits and Restore Neural Function
- (2020) Man Xiong et al. Cell Stem Cell
- Indirect treatment comparison of the efficacy of patisiran and inotersen for hereditary transthyretin-mediated amyloidosis with polyneuropathy
- (2020) Peter Gorevic et al. EXPERT OPINION ON PHARMACOTHERAPY
- Alzheimer’s protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity
- (2020) Colleen S. Limegrover et al. JOURNAL OF NEUROCHEMISTRY
- Generation of a human induced pluripotent stem cell line (UEFi003-A) carrying heterozygous A673T variant in amyloid precursor protein associated with a reduced risk of Alzheimer’s disease
- (2020) Taisia Rolova et al. Stem Cell Research
- Optimization of in vitro gene delivery to neurons containing an APP gene with a mutation responsible for familial Alzheimer’s disease for the development of a base editing therapy
- (2020) Jacques P. Tremblay et al. Alzheimers & Dementia
- The protective mutation A673T in amyloid precursor protein gene decreases Aβ peptides production for 14 forms of Familial Alzheimer’s Disease in SH-SY5Y cells
- (2020) Antoine Guyon et al. PLoS One
- HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
- (2019) Ravindra K. Gupta et al. NATURE
- Luxturna: FDA documents reveal the value of a costly gene therapy
- (2019) Jonathan J. Darrow DRUG DISCOVERY TODAY
- Ethics of Human Genome Editing
- (2019) Barry S. Coller Annual Review of Medicine
- Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
- (2019) Lisa Vermunt et al. Alzheimers & Dementia
- An evaluation of patisiran: a viable treatment option for transthyretin-related hereditary amyloidosis
- (2019) Paolo Milani et al. EXPERT OPINION ON PHARMACOTHERAPY
- Distance-based protein folding powered by deep learning
- (2019) Jinbo Xu PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The “rights” of precision drug development for Alzheimer’s disease
- (2019) Jeffrey Cummings et al. Alzheimers Research & Therapy
- Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
- (2019) Justin M. Long et al. CELL
- A resurrection of aducanumab for Alzheimer's disease
- (2019) Lon Schneider LANCET NEUROLOGY
- Protein threading using residue co-variation and deep learning
- (2018) Jianwei Zhu et al. BIOINFORMATICS
- Targeting Alzheimer's disease with gene and cell therapies
- (2018) R. Loera-Valencia et al. JOURNAL OF INTERNAL MEDICINE
- Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy
- (2018) Dongsheng Duan MOLECULAR THERAPY
- Differential effect of amyloid beta peptides on mitochondrial axonal trafficking depends on their state of aggregation and binding to the plasma membrane
- (2018) Liang Zhang et al. NEUROBIOLOGY OF DISEASE
- The Effects of N-terminal Mutations on β-amyloid Peptide Aggregation and Toxicity
- (2018) B.V. Foroutanpay et al. NEUROSCIENCE
- Generation of a human induced pluripotent stem cell line from a patient with a rare A673T variant in amyloid precursor protein gene that reduces the risk for Alzheimer's disease
- (2018) Šárka Lehtonen et al. Stem Cell Research
- Stem cell- and gene-based therapies as potential candidates in Alzheimer's therapy
- (2018) Seyede Atefe Hosseini et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Preclinical to phase II amyloid beta (Aβ) peptide modulators under investigation for Alzheimer’s disease
- (2017) Chris G. Parsons et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Familial Alzheimer's Disease Mutations within the Amyloid Precursor Protein Alter the Aggregation and Conformation of the Amyloid-β Peptide
- (2017) Asa Hatami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis
- (2017) Shuting Zhang et al. JOURNAL OF NEUROSCIENCE
- BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer’s Disease Pathology
- (2017) Gerald Koelsch MOLECULES
- Gleevec shifts APP processing from a β-cleavage to a nonamyloidogenic cleavage
- (2017) William J. Netzer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Semagacestat Is a Pseudo-Inhibitor of γ-Secretase
- (2017) Shinji Tagami et al. Cell Reports
- β-Amyloid Prions and the Pathobiology of Alzheimer’s Disease
- (2017) Joel C. Watts et al. Cold Spring Harbor Perspectives in Medicine
- Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence
- (2016) Ayano Kimura et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Molecular Structure of Aggregated Amyloid-β: Insights from Solid-State Nuclear Magnetic Resonance
- (2016) Robert Tycko Cold Spring Harbor Perspectives in Medicine
- c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease
- (2016) Ramon Yarza et al. Frontiers in Pharmacology
- Investor Outlook: Rising from the Ashes; GSK's European Approval of Strimvelis for ADA-SCID
- (2016) Joshua Schimmer et al. Human Gene Therapy Clinical Development
- Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis
- (2015) Kirsten L. Viola et al. ACTA NEUROPATHOLOGICA
- The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features
- (2015) Rik Ossenkoppele et al. BRAIN
- η-Secretase processing of APP inhibits neuronal activity in the hippocampus
- (2015) Michael Willem et al. NATURE
- The APP A673T frequency differs between Nordic countries
- (2015) Jonas Mengel-From et al. NEUROBIOLOGY OF AGING
- JPred4: a protein secondary structure prediction server
- (2015) Alexey Drozdetskiy et al. NUCLEIC ACIDS RESEARCH
- Rarity of the Alzheimer Disease–ProtectiveAPPA673T Variant in the United States
- (2015) Li-San Wang et al. JAMA Neurology
- Alzheimer's disease
- (2015) Colin L. Masters et al. Nature Reviews Disease Primers
- The A673T mutation in the amyloid precursor protein reduces the production of β-amyloid protein from its β-carboxyl terminal fragment in cells
- (2015) Asuka Kokawa et al. Acta Neuropathologica Communications
- A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease
- (2014) Eric Karran et al. ANNALS OF NEUROLOGY
- Beyond pathology: APP, brain development and Alzheimer's disease
- (2014) Alessia Soldano et al. CURRENT OPINION IN NEUROBIOLOGY
- Molecular Mechanisms of Alzheimer Disease Protection by the A673T Allele of Amyloid Precursor Protein
- (2014) Janice A. Maloney et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity
- (2014) Yuichi Hashimoto et al. JOURNAL OF NEUROCHEMISTRY
- Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
- (2014) Shichun Tu et al. Molecular Neurodegeneration
- Investigation of an amyloid precursor protein protective mutation (A673T) in a North American case-control sample of late-onset Alzheimer's disease
- (2014) Mikhil N. Bamne et al. NEUROBIOLOGY OF AGING
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protein threading using context-specific alignment potential
- (2013) J. Ma et al. BIOINFORMATICS
- Absence of A673T amyloid-β precursor protein variant in Alzheimer's disease and other neurological diseases
- (2013) Simon Kang Seng Ting et al. NEUROBIOLOGY OF AGING
- Absence of A673T variant in APP gene indicates an alternative protective mechanism contributing to longevity in Chinese individuals
- (2013) Yao-Wen Liu et al. NEUROBIOLOGY OF AGING
- Substrate ectodomain is critical for substrate preference and inhibition of γ-secretase
- (2013) Satoru Funamoto et al. Nature Communications
- A conditional neural fields model for protein threading
- (2012) Jianzhu Ma et al. BIOINFORMATICS
- Endgame: Glybera Finally Recommended for Approval as the First Gene Therapy Drug in the European Union
- (2012) Seppo Ylä-Herttuala MOLECULAR THERAPY
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
- (2012) Thorlakur Jonsson et al. NATURE
- Template-based protein structure modeling using the RaptorX web server
- (2012) Morten Källberg et al. Nature Protocols
- Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease
- (2012) Adam S. Fleisher et al. NEUROBIOLOGY OF AGING
- Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population
- (2012) Mia Kero et al. NEUROBIOLOGY OF AGING
- Human apoE Isoforms Differentially Regulate Brain Amyloid- Peptide Clearance
- (2011) J. M. Castellano et al. Science Translational Medicine
- APP processing in Alzheimer's disease
- (2011) Yun-wu Zhang et al. Molecular Brain
- Transforming Growth Factor β2 Level is Elevated in Neurons of Alzheimer's Disease Brains
- (2010) Atsushi Noguchi et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: Evidence for Aβ25–35
- (2009) Yury G. Kaminsky et al. EXPERIMENTAL NEUROLOGY
- Mutant Presenilin 1 Increases the Expression and Activity of BACE1
- (2009) Luca Giliberto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibrillar amyloid- burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
- (2009) E. M. Reiman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Recessive Mutation in the APP Gene with Dominant-Negative Effect on Amyloidogenesis
- (2009) G. Di Fede et al. SCIENCE
- Active γ-secretase is localized to detergent-resistant membranes in human brain
- (2008) Ji-Yeun Hur et al. FEBS Journal
- Conformational characterization of oligomeric intermediates and aggregates in β-lactoglobulin heat aggregation
- (2002) Rita Carrotta et al. PROTEIN SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started